Correction to Silencing PCMT1 enhances the sensitivity of breast cancer cells to paclitaxel through the PI3K/Akt/STMN1 pathway

IF 3.2 4区医学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY

Chemical Biology & Drug Design Pub Date : 2024-07-09 DOI:10.1111/cbdd.14577

引用次数: 0

Abstract

Zhang K, Li JY, Li K. Silencing PCMT1 enhances the sensitivity of breast cancer cells to paclitaxel through the PI3K/Akt/STMN1 pathway. Chem Biol Drug Des. 2024 Jun;103(6):e14559. doi: 10.1111/cbdd.14559. PMID: 38853025.

In page 1 of Author Information section, the text “Correspondence Kai Li, Department of Oncology, Renmin Hospital, Hubei University of Medicine, Shiyan 442000, Hubei, China. Email: [email protected]” was incorrect. This should have read: “Correspondence Kai Li, Department of Pathology, Renmin Hospital, Hubei University of Medicine, Shiyan 442000, Hubei, China. Email: [email protected].”

We apologize for this error.

查看原文本刊更多论文

更正为沉默 PCMT1 可通过 PI3K/Akt/STMN1 途径提高乳腺癌细胞对紫杉醇的敏感性。

Zhang K, Li JY, Li K. Silencing PCMT1 enhanced the sensitivity of breast cancer cells to paclitaxel through the PI3K/Akt/STMN1 pathway.Chem Biol Drug Des.2024 Jun;103(6):e14559. Doi: 10.1111/cbdd.14559.PMID：38853025.第1页 "作者信息 "中的 "通讯作者：湖北十堰442000 湖北医药学院附属人民医院肿瘤科李凯"。电子邮箱：[email protected]"有误：[email protected]"有误。应改为"Correspondence Kai Li, Department of Pathology, Renmin Hospital, Hubei University of Medicine, Shiyan 442000, Hubei, China.电子邮箱：[email protected]：[email protected]。"我们对此错误深表歉意。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Chemical Biology & Drug Design 医学-生化与分子生物学

CiteScore

5.10

自引率

3.30%

发文量

164

审稿时长

4.4 months

期刊介绍： Chemical Biology & Drug Design is a peer-reviewed scientific journal that is dedicated to the advancement of innovative science, technology and medicine with a focus on the multidisciplinary fields of chemical biology and drug design. It is the aim of Chemical Biology & Drug Design to capture significant research and drug discovery that highlights new concepts, insight and new findings within the scope of chemical biology and drug design.